Other Clinical Trial - Selective Ultrasound Screening for DDH 1991-2006

Status Completed

Clinical Trial Summary

Early treatment is considered essential for developmental dysplasia of the hip (DDH), but the choice of screening strategy is debated. The investigators evaluated the effect of a selective ultrasound (US) screening programme.

All infants born in a defined region during 1991-2006 with increased risk of DDH, i.e. clinical hip instability, breech presentation, congenital foot deformities or a family history of DDH, were subjected to US screening at age one to three days. Severe sonographic dysplasia and/or dislocatable/dislocated hips were treated with abduction splints. Mild dysplasia and/or pathological instability, i.e. not dislocatable/dislocated hips were followed clinically and sonographically until spontaneous resolution, or until treatment became necessary. The minimum observation period was 5,5 years.

Clinical Trial Description

Of 81564 newborns, 11539 (14,1%) were identified as at risk, of which 11190 (58% girls) were included for further analyses. Of the 81564 infants, 2433 (3•0%) received early treatment; 1882 (2,3%) from birth and 551 (0,7%) after six weeks or more of clinical and sonographic surveillance. Another 2700 (3,3%) normalised spontaneously after watchful waiting from birth. Twenty-six infants (0,32 per 1000, 92% girls, two from the risk group) presented with late subluxated/dislocated hips (after one month of age). Another 126 (1,5 per 1000, 83% girls, one from the risk group) were treated after isolated late residual dysplasia. Thirty-one children (0,38 per 1000) had surgical treatment before age five years. Avascular necrosis was diagnosed in seven of all children treated (0.27%), four after early and three after late treatment.

Interpretation The first 16 years of a standardised selective US screening programme for DDH resulted in acceptable rates of early treatment and US follow-ups, and low rates of late subluxated/dislocated hips compared to similar studies. ;

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

Developmental Dysplasia of the Hip
Hip Dislocation, Congenital

Clinical Trial Details

NCT number	NCT01866527
Study type	Observational
Source	University of Bergen
Contact
Status	Completed
Phase	N/A
Start date	January 1991
Completion date	August 2012

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT06007833` - Physical Therapy Applications on the Hip and Defined Functional Parameters in Children With Developmental Hip Dysplasia	N/A
Not yet recruiting	`NCT01437124` - Metal Ions in Ceramic on Metal Total Hip Arthroplasty	N/A
Enrolling by invitation	`NCT06439147` - Comparison Between Two Techniques of Capsulotomy During Capsulorrhaphy in Cases of Developmental Dysplasia of the Hip	N/A
Completed	`NCT05853510` - Mid-term Functional Comparisons of Unilateral and Bilateral Developmental Dysplasia of the Hip
Completed	`NCT05348421` - Postoperative Analgesic Effect of Two Peripheral Nerve Blocks for Hip Surgery in Pediatrics	N/A
Recruiting	`NCT03107520` - Intraoperative Contrast-Enhanced Ultrasound Evaluation of Blood Flow at the Time of Surgical Hip Reduction for DDH	Early Phase 1
Not yet recruiting	`NCT05822700` - Outcome Of Using Transfixing K Wire ln DDH With Hypoplastic Head And Severe Generalised Ligamentous Laxity	N/A
Not yet recruiting	`NCT06408987` - Arthroscopically Assisted Versus Open Surgical Reduction of the Hip in Patients With Irreducible DDH Before the Walking Age	N/A
Active, not recruiting	`NCT04101903` - Evaluation of Aid to Diagnosis for Congenital Dysplasia of the Hip in General Practice	N/A
Withdrawn	`NCT03859232` - Effectiveness of Cotton vs. Waterproof Cast Padding	N/A
Completed	`NCT04563819` - Genetic Mechanisms and Additional Risk Factors Underlying Hip Dysplasia
Active, not recruiting	`NCT05186168` - Corin MiniHip and Trinity Cup Clinical Surveillance Study
Recruiting	`NCT05188235` - Sound Conduction of Infant Hips	N/A
Completed	`NCT04007016` - A New Pelvic Osteotomy Method for Open Reduction
Not yet recruiting	`NCT06442722` - Surgical Treatment of DDH With and Without Capsulorrhaphy	N/A
Completed	`NCT03608475` - Assessing a Limited Ultrasound Protocol in DDH	N/A
Recruiting	`NCT02185365` - Evaluation of T1rho Magnetic Resonance Imaging for Diagnosis of Cartilage Lesions in Hips With Developmental Dysplasia
Completed	`NCT05929105` - AI-assisted Preoperative Planning Technology for THA for DDH
Active, not recruiting	`NCT02431871` - Sequelae of Developmental Dysplasia of the Hip
Completed	`NCT02945995` - Outcome After Arthroscopic Surgery in Patients Treated With PAO	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.